IRIS
DANESE, SILVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.955
NA - Nord America 1.927
AS - Asia 1.175
AF - Africa 23
OC - Oceania 13
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 6.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.893
SE - Svezia 1.429
SG - Singapore 798
RU - Federazione Russa 605
FI - Finlandia 324
CN - Cina 237
IT - Italia 213
DE - Germania 113
CZ - Repubblica Ceca 74
GB - Regno Unito 57
IE - Irlanda 41
IN - India 36
JP - Giappone 33
CA - Canada 27
NL - Olanda 24
FR - Francia 23
IR - Iran 14
ES - Italia 13
AU - Australia 11
PL - Polonia 10
EG - Egitto 9
EU - Europa 9
KR - Corea 9
HK - Hong Kong 8
CH - Svizzera 7
DZ - Algeria 7
SA - Arabia Saudita 7
ID - Indonesia 6
BE - Belgio 5
MA - Marocco 5
TW - Taiwan 5
VE - Venezuela 5
TR - Turchia 4
UA - Ucraina 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
KW - Kuwait 3
NI - Nicaragua 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MX - Messico 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
VN - Vietnam 2
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
HN - Honduras 1
HU - Ungheria 1
ME - Montenegro 1
MY - Malesia 1
PH - Filippine 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 6.115
Salva come PNG Salva come JPEG
Città #
Lawrence 702
Princeton 700
Singapore 469
Moscow 378
Helsinki 317
New York 157
Shanghai 114
Olomouc 73
Milan 46
Ashburn 44
Dublin 39
Borås 29
Boardman 28
London 18
Delhi 16
Los Angeles 15
Rome 14
Guangzhou 13
Seattle 13
Sendagaya 11
Saint Louis 10
Bologna 9
Beijing 8
Jiaxing 8
Shenzhen 8
St Louis 8
Lappeenranta 7
Mountain View 7
Nottingham 7
Versailles 7
New Hyde Park 6
Warsaw 6
Amsterdam 5
Frankfurt am Main 5
Naples 5
Pisa 5
Pune 5
Sunderland 5
Sydney 5
Taipei 5
Toronto 5
Baltimore 4
Cairo 4
Chennai 4
Dallas 4
Damietta 4
Hyderabad 4
Maidstone 4
Nishi-hiranumachō 4
Padova 4
Paris 4
Prineville 4
Tokyo 4
Adelaide 3
Aurora 3
Aversa 3
Berlin 3
Buenos Aires 3
Catania 3
Cherchell 3
Columbus 3
Dammam 3
Dongjak-gu 3
Frederick 3
Harrisburg 3
Inverigo 3
Kuwait City 3
Lanzhou 3
Malmo 3
Managua 3
Monza 3
Redwood City 3
Rockville 3
San Giovanni Rotondo 3
Shenyang 3
Spokane 3
Sunnyvale 3
Vigo 3
Wuxi 3
Xi'an 3
Ziefen 3
Zurich 3
Abu Dhabi 2
Aggius 2
Amman 2
Antalya 2
Astana 2
Barcelona 2
Barking 2
Barquisimeto 2
Benevento 2
Blida 2
Brescia 2
Buffalo 2
Camogli 2
Cellatica 2
Cergy 2
Chandigarh 2
Collazzone 2
Denpasar 2
Totale 3.503
Salva come PNG Salva come JPEG
Nome #
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 92
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 71
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 62
Crohn's disease 61
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 60
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 42
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 31
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 30
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 28
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 27
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 25
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 23
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 23
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 23
Publisher Correction: Crohn's disease 21
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 21
Colitis, microbiota and colon cancer: an infernal triangle 20
LONG-TERM SAFETY OF VEDOLIZUMAB IN ULCERATIVE COLITIS AND CROHN'S DISEASE: FINAL RESULTS FROM THE GEMINI LTS STUDY 20
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis 20
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 20
Clinical Pathologic Challenge Saxophone Penis: Challenge 19
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 19
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 19
JAK inhibitors: Novel developments in management of ulcerative colitis 19
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 19
Ustekinumab in the management of Crohn's disease: Expert opinion 19
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 19
A snapshot of the ongoing clinical research on COVID-19 19
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 19
LeMann Index Assessment Overtime in Crohn's Disease Patients Treated With Anti TNFs: A Pilot Observational Cohort Study 18
Application of Artificial Intelligence to Gastroenterology and Hepatology 18
E-health in inflammatory bowel diseases: More challenges than opportunities? 18
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 17
Clinical Pathologic Challenge Saxophone Penis: Challenge 17
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 17
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 17
JAK selectivity: more precision less troubles 17
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 17
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 17
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 17
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 17
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer 17
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL 17
Colon Staining Efficacy of Methylene Blue MMx (R) 25 mg Modified Release Tablets, Administered As Single Ascending Oral Doses of 150 and 200 mg in Outpatients Colonoscopy 17
Ulcerative Colitis 17
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 17
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 16
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 16
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 16
Has IBD specialists' awareness of biosimilar monoclonal antibodies changed? Results from a survey amongst ECCO members 16
PRESENTATION AND SURGICAL INTERVENTIONS FOR CROHN'S DISEASE WITH PERIANAL FISTULA IN THE BIOLOGICS ERA: RESULTS FROM A MULTICENTRE STUDY 16
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases 16
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 16
Cytapheresis in inflammatory bowel diseases: Current evidence and perspectives 16
Is cytotoxic-associated gene A-positive Helicobacter pylori important? 16
H. pylori gastric infection in rheumatic diseases 16
JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis 16
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 16
Ulcerative Colitis: A Cinderella Story 16
Colonic diverticular disease 16
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 15
Endoscopic internal drainage versus endoscopic vacuum therapy for upper gastrointestinal leaks: what's the real deal? 15
The VEGF-VEGF receptor (VEGF-R) pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (IBD) 15
The effects of vagus nerve stimulation in biologic-refractory Crohn's disease: A prospective clinical trial 15
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 15
Helicobacter pylori CagA positive strains determine oxidative DNA damage in gastric cells 15
Clinical Utility of the LeMann Index and Rutgeerts Score to Predict Postoperative Course of Crohn's Disease: A Retrospective Single-Center Cohort Study 15
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 15
MULTICENTRE ECCO COLLABORATIVE GROUP STUDY TO EVALUATE THE NEED FOR REINTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHN'S DISEASE WITH PERIANAL FISTULA 15
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 15
MULTICENTRE COHORT STUDY TO EVALUATE THE NEED FOR RE-INTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHNS DISEASE WITH PERIANAL FISTULA 15
Development of Red Flags for Early Referral of Adults With Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative 15
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 15
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 15
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 15
Inflammatory bowel disease: estimates from the global burden of disease 2017 study 15
Association between Helicobacter pylori cytotoxic type I strains and migraine with aura 15
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 15
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology 15
The biosimilar road in inflammatory bowel disease: The right way? 15
JAK inhibition in inflammatory bowel disease 15
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 15
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 14
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 14
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 14
Enhanced platelet adhesion induces angiogenesis in the IBD microcirculation 14
Head-to-head trials in inflammatory bowel disease: past, present and future 14
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 14
New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease 14
SELF-EXPANDABLE BIODEGRADABLE STENT IN THE MANAGEMENT OF REFRACTORY BENIGN COLORECTAL STRICTURES: PRELIMINARY RESULTS FROM A PILOT STUDY 14
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents 14
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 14
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (R) (Cortiment (R)(MMX (R))) for active, mild-to-moderate ulcerative colitis 14
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology 14
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 14
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open 14
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 14
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities 14
The safety of vedolizumab for ulcerative colitis and Crohn's disease 14
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study 14
Totale 1.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 1 0 0 0 0 0 0 0 0
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/20251.447 1.159 43 133 76 36 0 0 0 0 0 0 0
Totale 6.902